► 1:40 PARP Inhibitors as Treatment for Ovarian Cancer Oncology @GynCancerMD of @MountSinaiMiami discusses #PARPinhibitor #therapy for #ovariancancer.
► 14:41 Discussion of Oncology Paradigm Shifts Over Time Oncology Richard Quek, MBBS, discusses #paradigm shifts in #oncology over time.
► 21:50 Updates from ESMO 2022 in Colorectal Cancer Gastroenterology Chetan Desmukh, MBBS, of @DMHospitalPune, discusses #treatment for #colorectalcancer.
► 1:29:36 How Can Metastatic Brain Tumors Affect Lung Cancer Care? Neurology & Neurosurgery Erin Dunbar, MD, of @PiedmontHealth, Minesh Mehta, MD, of @MiamiCancerInst, Zosia Piotrawska, MD, MHS, of @MGHMedicine, and Rohan Ramakrishna, MD, of @WeillCornell discuss #brainmetastases in #lungcancer.
► 3:04 Combination Therapy Options for Blast Phase CML Treatment CML Content Hub @CoplandMhairi, of @UofGlasgow, discusses #combination #therapy for #CML.
► 1:11 Reducing Dosage to Manage Side Effects of Long-Term TKI Use CML Content Hub @CoplandMhairi, of @UofGlasgow, discusses #management of #side effects with long-term #TKI use.
► 06:40 Successful Treatment-Free Remission in Patients With CML After TKI Discontinuation CML Content Hub @FadiHaddad_MD, of @MDAndersonNews, discusses treatment-free remission in #CML.
► 26:24 Novel Strategies for Treating Meningiomas Neurology & Neurosurgery Nancy Ann Oberheim Bush, MD, PhD, of @NeurosurgUCSF, discusses #emerging #therapy for #meningiomas.
► 7:06 Timing Discontinuation of Treatment: Critical to Maximize Chances of Successful TFR CML Content Hub @FadiHaddad_MD, of @MDAndersonNews, discusses #treatment #discontinuation in #CML.
► 0:39 Additional Chromosomal Abnormalities in CML: An Indication for Close Monitoring CML Content Hub Susanne Saussele, MD, discusses the importance of #chromosome #abnormalities in #CML.
